PCM
OKUR

Pinz Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Pinz Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,836
Closed -$242K – 241
2021
Q4 		$242K Buy
2,836
+921
+48% +$67.6K 0.09% 203
2021
Q3 		$143K Sell
1,915
-3,767
-66% -$320K 0.06% 107
2021
Q2 		$530K Buy
+5,682
New +$634K 0.16% 91

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pinz Capital Management's OKUR Position: Q1 2022 in Review

Pinz Capital Management sold out of OnKure Therapeutics (OKUR) in Q1 2022, closing a stake of 2,836 shares — an estimated $242K sold.

Pinz Capital Management first reported a position in OKUR in Q2 2021 and held it in 3 quarters. The position peaked at $530K in Q2 2021. 41 funds tracked by Wall St. Rank hold OKUR as of Q1 2022.

  • Pinz Capital Management reported no remaining OnKure Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Pinz Capital Management sold 2,836 OnKure Therapeutics shares in Q1 2022, an estimated $242K.
  • Pinz Capital Management first reported a position in OnKure Therapeutics in Q2 2021 and held it in 3 quarters.
  • Pinz Capital Management's OnKure Therapeutics position peaked at $530K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2022.

Based on Pinz Capital Management's 13F filing for Q1 2022, filed 16 May 2022.